# RADIANT: Pre-op Radiation With Abemaciclib and Letrozole

> **NCT06139107** · PHASE1 · RECRUITING · sponsor: **Mridula George, MD** · enrollment: 15 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Abemaciclib
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT06139107
- **Lead sponsor:** Mridula George, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-22
- **Primary completion:** 2026-09-30
- **Final completion:** 2032-09-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06139107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06139107, "RADIANT: Pre-op Radiation With Abemaciclib and Letrozole". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06139107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*